Morningside Pharmaceuticals Ltd | Pharmaceutical Company

Morningside Launches Metabet® SR Tablets In The UK

Morningside Pharmaceuticals Limited is pleased to announce the launch of Metabet® SR (Metformin Prolonged Release) 1000mg into the UK market for the treatment of diabetes.

Fully licensed by the Medicines and Healthcare products Regulatory Authority (MHRA) in UK, Metabet® SR 1000mg Tablet, containing metformin hydrochloride, is a Prescription Only Medicine (POM) and is available in packs of 28s and 56s.

It follows the earlier launch of Metabet® SR 500mg (Metformin Prolonged Release) which continues to be distributed successfully to wholesalers and pharmacies in UK.

For further details about Metabet® SR please contact us.